{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:31:30Z","timestamp":1792452690286,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,21]]},"DOI":"10.7759\/cureus.26144","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T09:57:58Z","timestamp":1655805478000},"source":"Crossref","is-referenced-by-count":7,"title":["Vinculum of Cardiovascular Disease and Inflammatory Bowel Disease: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Ashujot Kaur","family":"Dang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeswar","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoushka","family":"Bali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna Kishore","family":"Anne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithin Kumar","family":"Konanur Srinivasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.028","article-title":"Diagnosis and classification of ulcerative colitis","volume":"13","author":"Conrad K","year":"2014","unstructured":"Conrad K, Roggenbuck D, Laass MW. Diagnosis and classification of ulcerative colitis. Autoimmun Rev. 2014, 13:463-6. 10.1016\/j.autrev.2014.01.028","journal-title":"Autoimmun Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.029","article-title":"Diagnosis and classification of Crohn's disease","volume":"13","author":"Laass MW","year":"2014","unstructured":"Laass MW, Roggenbuck D, Conrad K. Diagnosis and classification of Crohn's disease. Autoimmun Rev. 2014, 13:467-71. 10.1016\/j.autrev.2014.01.029","journal-title":"Autoimmun Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.04.007","article-title":"Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study","volume":"145","author":"Ng SC","year":"2013","unstructured":"Ng SC, Tang W, Ching JY, et al.. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology. 2013, 145:158-65. 10.1053\/j.gastro.2013.04.007","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.114.000918","article-title":"Prognosis after first-time myocardial infarction in patients with inflammatory bowel disease according to disease activity: nationwide cohort study","volume":"7","author":"Kristensen SL","year":"2014","unstructured":"Kristensen SL, Ahlehoff O, Lindhardsen J, et al.. Prognosis after first-time myocardial infarction in patients with inflammatory bowel disease according to disease activity: nationwide cohort study. Circulation. 2014, 7:857-62. 10.1161\/CIRCOUTCOMES.114.000918","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy354","article-title":"Risk of myocardial infarction in inflammatory bowel disease: a population-based national study","volume":"25","author":"Panhwar MS","year":"2019","unstructured":"Panhwar MS, Mansoor E, Al-Kindi SG, et al.. Risk of myocardial infarction in inflammatory bowel disease: a population-based national study. Inflammatory Bowel Dis. 2019, 25:1080-7. 10.1093\/ibd\/izy354","journal-title":"Inflammatory Bowel Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avi\u00f1a-Zubieta JA","year":"2008","unstructured":"Avi\u00f1a-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008, 59:1690-7. 10.1002\/art.24092","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman MJ","year":"2003","unstructured":"Roman MJ, Shanker BA, Davis A, et al.. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003, 349:2399-406. 10.1056\/NEJMoa035471","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3966","article-title":"Risk of cardiovascular disease in inflammatory bowel disease","volume":"13","author":"Wu P","year":"2017","unstructured":"Wu P, Jia F, Zhang B, Zhang P. Risk of cardiovascular disease in inflammatory bowel disease. Exp Ther Med. 2017, 13:395-400. 10.3892\/etm.2016.3966","journal-title":"Exp Ther Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-020-00639-y","article-title":"The risk of cardiovascular complications in inflammatory bowel disease","volume":"20","author":"Czubkowski P","year":"2020","unstructured":"Czubkowski P, Osiecki M, Szyma\u0144ska E, Kierku\u015b J. The risk of cardiovascular complications in inflammatory bowel disease. Clin Exp Med. 2020, 20:481-91. 10.1007\/s10238-020-00639-y","journal-title":"Clin Exp Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.63","article-title":"Inflammatory bowel disease is associated with an increased incidence of cardiovascular events","volume":"106","author":"Yarur AJ","year":"2011","unstructured":"Yarur AJ, Deshpande AR, Pechman DM, Tamariz L, Abreu MT, Sussman DA. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol. 2011, 106:741-7. 10.1038\/ajg.2011.63","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02031","article-title":"Stress and inflammation in coronary artery disease: a review psychoneuroendocrineimmunology-based","volume":"9","author":"Fioranelli M","year":"2018","unstructured":"Fioranelli M, Bottaccioli AG, Bottaccioli F, Bianchi M, Rovesti M, Roccia MG. Stress and inflammation in coronary artery disease: a review psychoneuroendocrineimmunology-based. Front Immunol. 2018, 9:2031. 10.3389\/fimmu.2018.02031","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"Grainge MJ","year":"2010","unstructured":"Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010, 375:657-63. 10.1016\/S0140-6736(09)61963-2","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis-an inflammatory disease","volume":"340","author":"Ross R","year":"1999","unstructured":"Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999, 340:115-26. 10.1056\/NEJM199901143400207","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv759","article-title":"Inflammatory cytokines in atherosclerosis: current therapeutic approaches","volume":"37","author":"Tousoulis D","year":"2016","unstructured":"Tousoulis D, Oikonomou E, Economou EK, Crea F, Kaski JC. Inflammatory cytokines in atherosclerosis: current therapeutic approaches. Eur Heart J. 2016, 37:1723-32. 10.1093\/eurheartj\/ehv759","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-016-0434-1","article-title":"Disruption of the Hedgehog signaling pathway in inflammatory bowel disease fosters chronic intestinal inflammation","volume":"17","author":"Buongusto F","year":"2017","unstructured":"Buongusto F, Bernardazzi C, Yoshimoto AN, et al.. Disruption of the Hedgehog signaling pathway in inflammatory bowel disease fosters chronic intestinal inflammation. Clin Exp Med. 2017, 17:351-69. 10.1007\/s10238-016-0434-1","journal-title":"Clin Exp Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham C","year":"2009","unstructured":"Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009, 361:2066-78. 10.1056\/NEJMra0804647","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson GK","year":"2005","unstructured":"Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005, 352:1685-95. 10.1056\/NEJMra043430","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.102.9.994","article-title":"Acute systemic inflammation impairs endothelium-dependent dilatation in humans","volume":"102","author":"Hingorani AD","year":"2000","unstructured":"Hingorani AD, Cross J, Kharbanda RK, et al.. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation. 2000, 102:994-9. 10.1161\/01.cir.102.9.994","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100229","article-title":"Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease","volume":"83","author":"Schinzari F","year":"2008","unstructured":"Schinzari F, Armuzzi A, De Pascalis B, Mores N, Tesauro M, Melina D, Cardillo C. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease. Clin Pharmacol Ther. 2008, 83:70-6. 10.1038\/sj.clpt.6100229","journal-title":"Clin Pharmacol Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050078","article-title":"Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review","volume":"5","author":"Danesh J","year":"2008","unstructured":"Danesh J, Kaptoge S, Mann AG, et al.. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 2008, 5:e78. 10.1371\/journal.pmed.0050078","journal-title":"PLoS Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.09.064","article-title":"VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis","volume":"136","author":"Scaldaferri F","year":"2009","unstructured":"Scaldaferri F, Vetrano S, Sans M, et al.. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology. 2009, 136:585-95. 10.1053\/j.gastro.2008.09.064","journal-title":"Gastroenterology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.207480","article-title":"Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: 'brothers in arms'","volume":"60","author":"Danese S","year":"2011","unstructured":"Danese S. Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: 'brothers in arms'. Gut. 2011, 60:998-1008. 10.1136\/gut.2010.207480","journal-title":"Gut"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(98)00667-5","article-title":"Factors involved in the maintenance of endothelial function","volume":"82","author":"Drexler H","year":"1998","unstructured":"Drexler H. Factors involved in the maintenance of endothelial function. Am J Cardiol. 1998, 82:3-4. 10.1016\/s0002-9149(98)00667-5","journal-title":"Am J Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000131515.03336.f8","article-title":"Role of endothelial dysfunction in atherosclerosis","volume":"109","author":"Davignon J","year":"2004","unstructured":"Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004, 109:27-32. 10.1161\/01.CIR.0000131515.03336.f8","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i3.1067","article-title":"Endothelial dysfunction in inflammatory bowel diseases: pathogenesis, assessment and implications","volume":"22","author":"Cibor D","year":"2016","unstructured":"Cibor D, Domagala-Rodacka R, Rodacki T, Jurczyszyn A, Mach T, Owczarek D. Endothelial dysfunction in inflammatory bowel diseases: pathogenesis, assessment and implications. World J Gastroenterol. 2016, 22:1067-77. 10.3748\/wjg.v22.i3.1067","journal-title":"World J Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200606000-00012","article-title":"Role of angiogenesis in inflammatory bowel disease","volume":"12","author":"Koutroubakis IE","year":"2006","unstructured":"Koutroubakis IE, Tsiolakidou G, Karmiris K, Kouroumalis EA. Role of angiogenesis in inflammatory bowel disease. Inflammatory Bowel Dis. 2006, 12:515-23. 10.1097\/00054725-200606000-00012","journal-title":"Inflammatory Bowel Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000168055.89955.db","article-title":"Arterial stiffness in chronic inflammatory diseases","volume":"46","author":"Roman MJ","year":"2005","unstructured":"Roman MJ, Devereux RB, Schwartz JE, et al.. Arterial stiffness in chronic inflammatory diseases. Hypertension. 2005, 46:194-9. 10.1161\/01.HYP.0000168055.89955.db","journal-title":"Hypertension"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000160548.78317.29","article-title":"Mechanisms, pathophysiology, and therapy of arterial stiffness","volume":"25","author":"Zieman SJ","year":"2005","unstructured":"Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005, 25:932-43. 10.1161\/01.ATV.0000160548.78317.29","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i40.11304","article-title":"Arterial structure and function in inflammatory bowel disease","volume":"21","author":"Zanoli L","year":"2015","unstructured":"Zanoli L, Rastelli S, Inserra G, Castellino P. Arterial structure and function in inflammatory bowel disease. World J Gastroenterol. 2015, 21:11304-11. 10.3748\/wjg.v21.i40.11304","journal-title":"World J Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283568abd","article-title":"Arterial stiffness is increased in patients with inflammatory bowel disease","volume":"30","author":"Zanoli L","year":"2012","unstructured":"Zanoli L, Cannav\u00f2 M, Rastelli S, et al.. Arterial stiffness is increased in patients with inflammatory bowel disease. J Hypertens. 2012, 30:1775-81. 10.1097\/HJH.0b013e3283568abd","journal-title":"J Hypertens"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1058","article-title":"Vascular calcification in patients with end-stage renal disease","volume":"19","author":"Floege J","year":"2004","unstructured":"Floege J, Ketteler M. Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant. 2004, 19:59-66. 10.1093\/ndt\/gfh1058","journal-title":"Nephrol Dial Transplant"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.026278","article-title":"The CD40\/CD40L costimulatory pathway in inflammatory bowel disease","volume":"53","author":"Danese S","year":"2004","unstructured":"Danese S, Sans M, Fiocchi C. The CD40\/CD40L costimulatory pathway in inflammatory bowel disease. Gut. 2004, 53:1035-43. 10.1136\/gut.2003.026278","journal-title":"Gut"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/nu13082661","article-title":"What links an increased cardiovascular risk and inflammatory bowel disease? A narrative review","volume":"13","author":"\u0141ykowska-Szuber L","year":"2021","unstructured":"\u0141ykowska-Szuber L, Rychter AM, Dudek M, et al.. What links an increased cardiovascular risk and inflammatory bowel disease? A narrative review. Nutrients. 2021, 13:2661. 10.3390\/nu13082661","journal-title":"Nutrients"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/nature10208","article-title":"Intestinal homeostasis and its breakdown in inflammatory bowel disease","volume":"474","author":"Maloy KJ","year":"2011","unstructured":"Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011, 474:298-306. 10.1038\/nature10208","journal-title":"Nature"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.12.025","article-title":"Indole and indoxyl sulfate, gut bacteria metabolites of tryptophan, change arterial blood pressure via peripheral and central mechanisms in rats","volume":"130","author":"Hu\u0107 T","year":"2018","unstructured":"Hu\u0107 T, Nowinski A, Drapala A, Konopelski P, Ufnal M. Indole and indoxyl sulfate, gut bacteria metabolites of tryptophan, change arterial blood pressure via peripheral and central mechanisms in rats. Pharmacol Res. 2018, 130:172-9. 10.1016\/j.phrs.2017.12.025","journal-title":"Pharmacol Res"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/ni1511","article-title":"Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses","volume":"8","author":"Denning TL","year":"2007","unstructured":"Denning TL, Wang YC, Patel SR, Williams IR, Pulendran B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol. 2007, 8:1086-94. 10.1038\/ni1511","journal-title":"Nat Immunol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.01.042","article-title":"Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology","volume":"146","author":"Nguyen GC","year":"2014","unstructured":"Nguyen GC, Bernstein CN, Bitton A, et al.. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. Gastroenterology. 2014, 146:835-48. 10.1053\/j.gastro.2014.01.042","journal-title":"Gastroenterology"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i33.9688","article-title":"Cardiovascular involvement in inflammatory bowel disease: dangerous liaisons","volume":"21","author":"Filimon AM","year":"2015","unstructured":"Filimon AM, Negreanu L, Doca M, Ciobanu A, Preda CM, Vinereanu D. Cardiovascular involvement in inflammatory bowel disease: dangerous liaisons. World J Gastroenterol. 2015, 21:9688-92. 10.3748\/wjg.v21.i33.9688","journal-title":"World J Gastroenterol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.09.016","article-title":"The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study","volume":"6","author":"Bernstein CN","year":"2008","unstructured":"Bernstein CN, Wajda A, Blanchard JF. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol. 2008, 6:41-5. 10.1016\/j.cgh.2007.09.016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.81","article-title":"Risk of arterial thrombotic events in inflammatory bowel disease","volume":"104","author":"Ha C","year":"2009","unstructured":"Ha C, Magowan S, Accortt NA, Chen J, Stone CD. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol. 2009, 104:1445-51. 10.1038\/ajg.2009.81","journal-title":"Am J Gastroenterol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21187","article-title":"Risk of ischemic stroke in patients with Crohn's disease: a population-based nested case-control study","volume":"16","author":"Andersohn F","year":"2010","unstructured":"Andersohn F, Waring M, Garbe E. Risk of ischemic stroke in patients with Crohn's disease: a population-based nested case-control study. Inflammatory Bowel Dis. 2010, 16:1387-92. 10.1002\/ibd.21187","journal-title":"Inflammatory Bowel Dis"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.08.023","article-title":"Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"12","author":"Singh S","year":"2014","unstructured":"Singh S, Singh H, Loftus EV Jr, Pardi DS. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014, 12:382-93. 10.1016\/j.cgh.2013.08.023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056944","article-title":"Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death-a Danish nationwide cohort study","volume":"8","author":"Kristensen SL","year":"2013","unstructured":"Kristensen SL, Ahlehoff O, Lindhardsen J, et al.. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death-a Danish nationwide cohort study. PLoS One. 2013, 8:e56944. 10.1371\/journal.pone.0056944","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.01.011","article-title":"Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients","volume":"5","author":"Sridhar AR","year":"2011","unstructured":"Sridhar AR, Parasa S, Navaneethan U, Crowell MD, Olden K. Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients. J Crohns Colitis. 2011, 5:287-94. 10.1016\/j.crohns.2011.01.011","journal-title":"J Crohns Colitis"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21113","article-title":"Cerebral thromboembolic events in pediatric patients with inflammatory bowel disease","volume":"16","author":"Barclay AR","year":"2010","unstructured":"Barclay AR, Keightley JM, Horrocks I, Garrick V, McGrogan P, Russell RK. Cerebral thromboembolic events in pediatric patients with inflammatory bowel disease. Inflammatory Bowel Dis. 2010, 16:677-83. 10.1002\/ibd.21113","journal-title":"Inflammatory Bowel Dis"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.114.001152","article-title":"Inflammatory bowel disease is associated with an increased risk of hospitalization for heart failure: a Danish Nationwide Cohort study","volume":"7","author":"Kristensen SL","year":"2014","unstructured":"Kristensen SL, Ahlehoff O, Lindhardsen J, et al.. Inflammatory bowel disease is associated with an increased risk of hospitalization for heart failure: a Danish Nationwide Cohort study. Circulation. 2014, 7:717-22. 10.1161\/CIRCHEARTFAILURE.114.001152","journal-title":"Circulation"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.09.021","article-title":"Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies","volume":"8","author":"Fumery M","year":"2014","unstructured":"Fumery M, Xiaocang C, Dauchet L, Gower-Rousseau C, Peyrin-Biroulet L, Colombel JF. Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis. 2014, 8:469-79. 10.1016\/j.crohns.2013.09.021","journal-title":"J Crohns Colitis"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000109","article-title":"Conventional risk factors and cardiovascular outcomes of patients with inflammatory bowel disease with confirmed coronary artery disease","volume":"20","author":"Aggarwal A","year":"2014","unstructured":"Aggarwal A, Atreja A, Kapadia S, Lopez R, Achkar JP. Conventional risk factors and cardiovascular outcomes of patients with inflammatory bowel disease with confirmed coronary artery disease. Inflammatory Bowel Dis. 2014, 20:1593-601. 10.1097\/MIB.0000000000000109","journal-title":"Inflammatory Bowel Dis"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2010.09.008","article-title":"Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease","volume":"5","author":"Haapam\u00e4ki J","year":"2011","unstructured":"Haapam\u00e4ki J, Roine RP, Turunen U, F\u00e4rkkil\u00e4 MA, Arkkila PE. Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease. J Crohns Colitis. 2011, 5:41-7. 10.1016\/j.crohns.2010.09.008","journal-title":"J Crohns Colitis"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303285","article-title":"Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study","volume":"62","author":"Rungoe C","year":"2013","unstructured":"Rungoe C, Basit S, Ranthe MF, Wohlfahrt J, Langholz E, Jess T. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study. Gut. 2013, 62:689-94. 10.1136\/gutjnl-2012-303285","journal-title":"Gut"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.01018.x","article-title":"Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis","volume":"102","author":"Dorn SD","year":"2007","unstructured":"Dorn SD, Sandler RS. Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. Am J Gastroenterol. 2007, 102:662-7. 10.1111\/j.1572-0241.2006.01018.x","journal-title":"Am J Gastroenterol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e31827f27ae","article-title":"Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis","volume":"19","author":"Bewtra M","year":"2013","unstructured":"Bewtra M, Kaiser LM, TenHave T, Lewis JD. Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis. Inflammatory Bowel Dis. 2013, 19:599-613. 10.1097\/MIB.0b013e31827f27ae","journal-title":"Inflammatory Bowel Dis"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.2174\/1389450116666150202161500","article-title":"Cardiovascular complications in inflammatory bowel disease","volume":"16","author":"Schicho R","year":"2015","unstructured":"Schicho R, Marsche G, Storr M. Cardiovascular complications in inflammatory bowel disease. Curr Drug Targets. 2015, 16:181-8. 10.2174\/1389450116666150202161500","journal-title":"Curr Drug Targets"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200311000-00016","article-title":"Hyperhomocystinemia in children with inflammatory bowel disease","volume":"37","author":"Nakano E","year":"2003","unstructured":"Nakano E, Taylor CJ, Chada L, McGaw J, Powers HJ. Hyperhomocystinemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2003, 37:586-90. 10.1097\/00005176-200311000-00016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21563","article-title":"Thromboembolism in pediatric inflammatory bowel disease: systematic review","volume":"17","author":"Lazzerini M","year":"2011","unstructured":"Lazzerini M, Bramuzzo M, Maschio M, Martelossi S, Ventura A. Thromboembolism in pediatric inflammatory bowel disease: systematic review. Inflammatory Bowel Dis. 2011, 17:2174-83. 10.1002\/ibd.21563","journal-title":"Inflammatory Bowel Dis"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/apa.15237","article-title":"Cardiovascular risk factors are not present in adolescents with inflammatory bowel disease","volume":"109","author":"Dorfman L","year":"2020","unstructured":"Dorfman L, Ghersin I, Khateeb N, Daher S, Shamir R, Assa A. Cardiovascular risk factors are not present in adolescents with inflammatory bowel disease. Acta Paediatr. 2020, 109:2380-7. 10.1111\/apa.15237","journal-title":"Acta Paediatr"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-017-2927-7","article-title":"Pulse wave velocity measurement as a marker of arterial stiffness in pediatric inflammatory bowel disease: a pilot study","volume":"176","author":"Lurz E","year":"2017","unstructured":"Lurz E, Aeschbacher E, Carman N, Schibli S, Sokollik C, Simonetti GD. Pulse wave velocity measurement as a marker of arterial stiffness in pediatric inflammatory bowel disease: a pilot study. Eur J Pediatr. 2017, 176:983-7. 10.1007\/s00431-017-2927-7","journal-title":"Eur J Pediatr"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31829ce5cd","article-title":"Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease","volume":"57","author":"Zitomersky NL","year":"2013","unstructured":"Zitomersky NL, Levine AE, Atkinson BJ, et al.. Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013, 57:343-7. 10.1097\/MPG.0b013e31829ce5cd","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2019.10.001","article-title":"Inflammatory bowel disease and the risk for cardiovascular disease: does all inflammation lead to heart disease?","volume":"30","author":"Bigeh A","year":"2020","unstructured":"Bigeh A, Sanchez A, Maestas C, Gulati M. Inflammatory bowel disease and the risk for cardiovascular disease: does all inflammation lead to heart disease?. Trends Cardiovasc Med. 2020, 30:463-9. 10.1016\/j.tcm.2019.10.001","journal-title":"Trends Cardiovasc Med"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2014.985708","article-title":"Low incidence of venous thromboembolism in inflammatory bowel diseases: prevalence and predictors from a population-based inception cohort","volume":"50","author":"Vegh Z","year":"2015","unstructured":"Vegh Z, Golovics PA, Lovasz BD, et al.. Low incidence of venous thromboembolism in inflammatory bowel diseases: prevalence and predictors from a population-based inception cohort. Scand J Gastroenterol. 2015, 50:306-11. 10.3109\/00365521.2014.985708","journal-title":"Scand J Gastroenterol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1601049","article-title":"Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls","volume":"54","author":"Geerling BJ","year":"2000","unstructured":"Geerling BJ, Badart-Smook A, Stockbr\u00fcgger RW, Brummer RJ. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr. 2000, 54:514-21. 10.1038\/sj.ejcn.1601049","journal-title":"Eur J Clin Nutr"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/71.3.807","article-title":"Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease","volume":"71","author":"Levy E","year":"2000","unstructured":"Levy E, Rizwan Y, Thibault L, Lepage G, Brunet S, Bouthillier L, Seidman E. Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease. Am J Clin Nutr. 2000, 71:807-15. 10.1093\/ajcn\/71.3.807","journal-title":"Am J Clin Nutr"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07520.x","article-title":"Body composition in patients with inflammatory bowel disease: a population-based study","volume":"98","author":"Jahnsen J","year":"2003","unstructured":"Jahnsen J, Falch JA, Mowinckel P, et al.. Body composition in patients with inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2003, 98:1556-62. 10.1111\/j.1572-0241.2003.07520.x","journal-title":"Am J Gastroenterol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.765474","article-title":"Treatment of inflammatory bowel disease: a comprehensive review","volume":"8","author":"Cai Z","year":"2021","unstructured":"Cai Z, Wang S, Li J. Treatment of inflammatory bowel disease: a comprehensive review. Front Med. 2021, 8:765474. 10.3389\/fmed.2021.765474","journal-title":"Front Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2015.03.010","article-title":"Inflammatory bowel disease and risk of coronary heart disease","volume":"25","author":"Rungoe C","year":"2015","unstructured":"Rungoe C, Nyboe Andersen N, Jess T. Inflammatory bowel disease and risk of coronary heart disease. Trends Cardiovasc Med. 2015, 25:699-704. 10.1016\/j.tcm.2015.03.010","journal-title":"Trends Cardiovasc Med"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2014.03.023","article-title":"Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs","volume":"234","author":"Zanoli L","year":"2014","unstructured":"Zanoli L, Rastelli S, Inserra G, et al.. Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs. Atherosclerosis. 2014, 234:346-51. 10.1016\/j.atherosclerosis.2014.03.023","journal-title":"Atherosclerosis"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp18X699341","article-title":"Using corticosteroids appropriately in inflammatory bowel disease: a guide for primary care","volume":"68","author":"Barrett K","year":"2018","unstructured":"Barrett K, Saxena S, Pollok R. Using corticosteroids appropriately in inflammatory bowel disease: a guide for primary care. Br J Gen Pract. 2018, 68:497-8. 10.3399\/bjgp18X699341","journal-title":"Br J Gen Pract"},{"key":"ref68","article-title":"Tumor Necrosis Factor-Alpha Antagonists and Cardiovascular Disease in Inflammatory Bowel Disease","author":"Andersen NN","year":"2013","unstructured":"Andersen NN, Rungoe C, Andersson M, et al.. Tumor Necrosis Factor-Alpha Antagonists and Cardiovascular Disease in Inflammatory Bowel Disease. European Crohn Colitis Organisation Congress, Vienna, Austria; 2013."},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21822","article-title":"Statins are associated with reduced use of steroids in inflammatory bowel disease: a retrospective cohort study","volume":"18","author":"Crockett SD","year":"2012","unstructured":"Crockett SD, Hansen RA, St\u00fcrmer T, Schectman R, Darter J, Sandler RS, Kappelman MD. Statins are associated with reduced use of steroids in inflammatory bowel disease: a retrospective cohort study. Inflammatory Bowel Dis. 2012, 18:1048-56. 10.1002\/ibd.21822","journal-title":"Inflammatory Bowel Dis"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.2174\/1389450121666200902164240","article-title":"Thrombosis in IBD in the era of JAK Inhibition","volume":"22","author":"Solitano V","year":"2021","unstructured":"Solitano V, Fiorino G, D'Amico F, Peyrin-Biroulet L, Danese S. Thrombosis in IBD in the era of JAK Inhibition. Curr Drug Targets. 2021, 22:126-36. 10.2174\/1389450121666200902164240","journal-title":"Curr Drug Targets"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2020.1714650","article-title":"Comparative of the effectiveness and safety of biological agents, tofacitinib, and fecal microbiota transplantation in ulcerative colitis: systematic review and network meta-analysis","volume":"50","author":"Zhou HY","year":"2021","unstructured":"Zhou HY, Guo B, Lufumpa E, Li XM, Chen LH, Meng X, Li BZ. Comparative of the effectiveness and safety of biological agents, tofacitinib, and fecal microbiota transplantation in ulcerative colitis: systematic review and network meta-analysis. Immunol Invest. 2021, 50:323-37. 10.1080\/08820139.2020.1714650","journal-title":"Immunol Invest"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.3390\/nu9030259","article-title":"An examination of diet for the maintenance of remission in inflammatory bowel disease","volume":"9","author":"Haskey N","year":"2017","unstructured":"Haskey N, Gibson DL. An examination of diet for the maintenance of remission in inflammatory bowel disease. Nutrients. 2017, 9:259. 10.3390\/nu9030259","journal-title":"Nutrients"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx071","article-title":"Dietary therapy with the Crohn's disease exclusion diet is a successful strategy for induction of remission in children and adults failing biological therapy","volume":"11","author":"Sigall Boneh R","year":"2017","unstructured":"Sigall Boneh R, Sarbagili Shabat C, Yanai H, Chermesh I, Ben Avraham S, Boaz M, Levine A. Dietary therapy with the Crohn's disease exclusion diet is a successful strategy for induction of remission in children and adults failing biological therapy. J Crohns Colitis. 2017, 11:1205-12. 10.1093\/ecco-jcc\/jjx071","journal-title":"J Crohns Colitis"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3390\/nu12082436","article-title":"Diet and cardiovascular disease risk among individuals with familial hypercholesterolemia: systematic review and meta-analysis","volume":"12","author":"Barkas F","year":"2020","unstructured":"Barkas F, Nomikos T, Liberopoulos E, Panagiotakos D. Diet and cardiovascular disease risk among individuals with familial hypercholesterolemia: systematic review and meta-analysis. Nutrients. 2020, 12:2436. 10.3390\/nu12082436","journal-title":"Nutrients"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2011-301345","article-title":"Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg)","volume":"98","author":"Li K","year":"2012","unstructured":"Li K, Kaaks R, Linseisen J, Rohrmann S. Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart. 2012, 98:920-5. 10.1136\/heartjnl-2011-301345","journal-title":"Heart"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3691","article-title":"Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis","volume":"341","author":"Bolland MJ","year":"2010","unstructured":"Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010, 341:c3691. 10.1136\/bmj.c3691","journal-title":"BMJ"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(01)01138-x","article-title":"Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial","volume":"112","author":"Reid IR","year":"2002","unstructured":"Reid IR, Mason B, Horne A, et al.. Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med. 2002, 112:343-7. 10.1016\/s0002-9343(01)01138-x","journal-title":"Am J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/100063-vinculum-of-cardiovascular-disease-and-inflammatory-bowel-disease-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:39Z","timestamp":1707507939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/100063-vinculum-of-cardiovascular-disease-and-inflammatory-bowel-disease-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":77,"URL":"https:\/\/doi.org\/10.7759\/cureus.26144","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,21]]}}}